Literature DB >> 9932613

Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation.

A Giatromanolaki1, G Fountzilas, M I Koukourakis, P Arapandoni, V Theologi, S Kakolyris, V Georgoulias, A L Harris, K C Gatter.   

Abstract

Thymidine phosphorylase (Th.P) is an angiogenic factor shown to induce endothelial cell migration and proliferation. On the other hand, loss of wild type p53 function leads to down-regulation of thrombospondin-1, an inhibitor of angiogenesis. In this immunohistochemical study we investigated the intratumoural angiogenesis and thymidine phosphorylase (Th.P) expression in paraffin-embedded bioptical material from 104 locally advanced squamous cell head and neck cancers. The nuclear accumulation of mutant p53 protein and the cytoplasmic expression of bcl-2 protein was also assessed. High vascular grade was observed in 56% and high Th.P tumour cell reactivity in 48% of cases. High microvessel score was associated with an increased percentage of cancer cells expressing thymidine phosphorylase (P = 0.001). Increased p53 nuclear accumulation also correlated with high vascular grade (P = 0.001). High histological grade and absence of bcl-2 overexpression were associated with lymph node involvement (P = 0.002 and P = 0.02 respectively). No correlation of clinically detected lymphadenopathy with angiogenesis and p53 was observed. We conclude that intense neo-angiogenesis in locally advanced squamous cell head neck cancer is a frequent event, which is associated with nuclear p53 accumulation and thymidine phosphorylase overexpression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9932613     DOI: 10.1023/a:1006554512338

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  43 in total

Review 1.  Molecular and biological properties of the vascular endothelial growth factor family of proteins.

Authors:  N Ferrara; K Houck; L Jakeman; D W Leung
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

2.  Relation of neovascularisation to metastasis of non-small-cell lung cancer.

Authors:  P Macchiarini; G Fontanini; M J Hardin; F Squartini; C A Angeletti
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

3.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

Review 4.  Adjuvant chemotherapy of head and neck cancer: the past, the present, and the future.

Authors:  A J Choksi; I W Dimery; W K Hong
Journal:  Semin Oncol       Date:  1988-06       Impact factor: 4.929

5.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

6.  Neoplastic stroma and epithelium show up-regulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in colorectal carcinomas but not adenomas.

Authors:  L Kaklamanis; S Kakolyris; H Turley; M Koukourakis; S Biddolph; K C Gatter; A L Harris
Journal:  Angiogenesis       Date:  1998       Impact factor: 9.596

7.  Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.

Authors:  G Fontanini; D Bigini; S Vignati; F Basolo; A Mussi; M Lucchi; S Chine; C A Angeletti; A L Harris; G Bevilacqua
Journal:  J Pathol       Date:  1995-09       Impact factor: 7.996

8.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

Review 9.  The fibroblast growth factor family: structural and biological properties.

Authors:  M Klagsbrun
Journal:  Prog Growth Factor Res       Date:  1989

10.  The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck.

Authors:  D Albo; M S Granick; N Jhala; B Atkinson; M P Solomon
Journal:  Ann Plast Surg       Date:  1994-06       Impact factor: 1.539

View more
  6 in total

1.  Thymidine phosphorylase expression in endometrial carcinomas.

Authors:  E Sivridis; A Giatromanolaki; M I Koukourakis; R Bicknell; A L Harris; K C Gatter
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; P E Thorpe; R A Brekken; S Konstantinos; G Fountzilas; K C Gatter; A L Harris
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.

Authors:  M I Koukourakis; A Giatromanolaki; K J O'Byrne; J Cox; B Krammer; K C Gatter; A L Harris
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 4.  Thymidine phosphorylase: A potential new target for treating cardiovascular disease.

Authors:  Wei Li; Hong Yue
Journal:  Trends Cardiovasc Med       Date:  2017-10-20       Impact factor: 6.677

5.  Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.

Authors:  E Sivridis; A Giatromanolaki; I Papadopoulos; K C Gatter; A L Harris; M I Koukourakis
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

6.  Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis.

Authors:  S Marchetti; M Chazal; A Dubreuil; J L Fischel; M C Etienne; G Milano
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.